PNC Financial Services Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
CUAMC
PNC Financial Services Group's LKFT Position: Q2 2026 in Review
PNC Financial Services Group reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9.1% in Q2 2026, selling an estimated $57 and leaving 20 shares worth $600. The position accounts for ﹤0.01% of the portfolio, ranked #4949.
PNC Financial Services Group first reported a position in LKFT in Q4 2017 and has held it in 19 quarters since. The position peaked at $39K in Q2 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- PNC Financial Services Group held 20 shares of Lakefront Biotherapeutics American Depositary Shares worth $600 as of Q2 2026.
- PNC Financial Services Group sold 2 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $57.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4949 holding.
- PNC Financial Services Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and has held it in 19 quarters since.
- PNC Financial Services Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $39K in Q2 2020.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.